Summary: CRISPR/Cas9-engineered Endoglin deficiency in zebrafish recapitulates critical aspects of hereditary hemorrhagic telangiectasia (HHT) and thus provides a valuable model for use in large-scale screens of HHT-active compounds. Here, ENG is linked to hereditary hemorrhagic telangiectasia.